Colon Cancer Clinical Trial

Exercise and Colon Cancer

Summary

Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aims to identify the dose-response effects of aerobic exercise on molecular and cellular pathways associated with physical activity and CC outcomes among patients with stage II and III CC.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

histologically confirmed TNM stage II-III CC;
completed surgical resection and adjuvant chemotherapy (if applicable) within 1-24 months before entering the study;
≤120 min/wk of self-reported moderate or vigorous intensity physical activity using the Paffenbarger physical activity questionnaire;
age ≥18 years;
written physician approval;
no additional surgery planned within the 6-month intervention (including colostomy reversal);
ability to walk unaided for 6-minutes;
no contraindications to exercise using the PA readiness questionnaire (PAR-Q), unless physician approves participation with specific knowledge of this contraindication.

Exclusion Criteria:

history of another primary invasive cancer (other than non-melanoma skin-cancer);
evidence of metastatic CC (i.e., TNM M1);
planning to receive any additional adjuvant chemotherapy;
pregnant or breast feeding;
unable to provide baseline blood sample;

cardiac conditions, including the following:

myocardial infarction or coronary revascularization procedure within prior 3 months;
uncontrolled hypertension (systolic ≥180 mmHg or diastolic ≥100 mmHg);
high-risk or uncontrolled arrhythmias;
clinically significant valvular disease;
decompensated heart failure;
known aortic aneurysm;
any other condition that may impede testing of the study hypothesis or make it unsafe to engage in the exercise program (determined by the investigative team).

Study is for people with:

Colon Cancer

Estimated Enrollment:

44

Study ID:

NCT02250053

Recruitment Status:

Completed

Sponsor:

Abramson Cancer Center of the University of Pennsylvania

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Abramson Cancer Center of the University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

44

Study ID:

NCT02250053

Recruitment Status:

Completed

Sponsor:


Abramson Cancer Center of the University of Pennsylvania

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider